Back to XENE
BlackRock, Inc. XENE Position History
Xenon Pharmaceuticals Inc. • Healthcare
Quarters held
59
Latest value
$3.1M
Q3 2026
Peak value
$258M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $2.7M |
| Q4 2025 | $18K |
| Q4 2025 | $826K |
| Q4 2025 | $10M |
| Q4 2025 | $10.1M |
| Q4 2025 | $147.1M |
| Q4 2025 | $44.7M |
| Q4 2025 | $14K |
| Q4 2025 | $440K |
| Q4 2025 | $1M |
| Q4 2025 | $7.8M |
| Q4 2025 | $899K |
| Q4 2025 | $10K |
| Q4 2025 | $447K |
| Q4 2025 | $2.5M |
| Q1 2026 | $4.8M |
| Q1 2026 | $11K |
| Q1 2026 | $1.1M |
| Q1 2026 | $14.1M |
| Q1 2026 | $14.6M |
| Q1 2026 | $206.9M |
| Q1 2026 | $66.6M |
| Q1 2026 | $64K |
| Q1 2026 | $731K |
| Q1 2026 | $1.3M |
| Q1 2026 | $12.3M |
| Q1 2026 | $13K |
| Q1 2026 | $773K |
| Q1 2026 | $4.7M |
| Q2 2026 | $8.8M |
| Q2 2026 | $12K |
| Q2 2026 | $1.3M |
| Q2 2026 | $18M |
| Q2 2026 | $33.7M |
| Q2 2026 | $258M |
| Q2 2026 | $98.8M |
| Q2 2026 | $322K |
| Q2 2026 | $953K |
| Q2 2026 | $3.1M |
| Q2 2026 | $25.3M |
| Q2 2026 | $296K |
| Q2 2026 | $14K |
| Q2 2026 | $802K |
| Q2 2026 | $4.7M |
| Q3 2026 | $9.2M |
| Q3 2026 | $7K |
| Q3 2026 | $1M |
| Q3 2026 | $10.8M |
| Q3 2026 | $17.9M |
| Q3 2026 | $163.2M |
| Q3 2026 | $61.7M |
| Q3 2026 | $191K |
| Q3 2026 | $244K |
| Q3 2026 | $1.4M |
| Q3 2026 | $82K |
| Q3 2026 | $17.4M |
| Q3 2026 | $9K |
| Q3 2026 | $494K |
| Q3 2026 | $3.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.1M | 83.0K | — | — |
| Q3 2026 | $494K | 13.3K | — | — |
| Q3 2026 | $9K | 230 | — | — |
| Q3 2026 | $17.4M | 468.4K | — | — |
| Q3 2026 | $82K | 2.2K | — | — |
| Q3 2026 | $1.4M | 38.7K | — | — |
| Q3 2026 | $244K | 6.5K | — | — |
| Q3 2026 | $191K | 5.1K | — | — |
| Q3 2026 | $61.7M | 1.66M | — | — |
| Q3 2026 | $163.2M | 4.39M | — | — |
| Q3 2026 | $17.9M | 481.1K | — | — |
| Q3 2026 | $10.8M | 290.0K | — | — |
| Q3 2026 | $1M | 27.7K | — | — |
| Q3 2026 | $7K | 197 | — | — |
| Q3 2026 | $9.2M | 246.2K | — | — |
| Q2 2026 | $4.7M | 78.4K | — | — |
| Q2 2026 | $802K | 13.3K | — | — |
| Q2 2026 | $14K | 230 | — | — |
| Q2 2026 | $296K | 4.9K | — | — |
| Q2 2026 | $25.3M | 418.7K | — | — |
| Q2 2026 | $3.1M | 50.8K | — | — |
| Q2 2026 | $953K | 15.8K | — | — |
| Q2 2026 | $322K | 5.3K | — | — |
| Q2 2026 | $98.8M | 1.64M | — | — |
| Q2 2026 | $258M | 4.28M | — | — |
| Q2 2026 | $33.7M | 558.5K | — | — |
| Q2 2026 | $18M | 298.8K | — | — |
| Q2 2026 | $1.3M | 20.7K | — | — |
| Q2 2026 | $12K | 197 | — | — |
| Q2 2026 | $8.8M | 145.6K | — | — |
| Q1 2026 | $4.7M | 80.3K | — | — |
| Q1 2026 | $773K | 13.3K | — | — |
| Q1 2026 | $13K | 230 | — | — |
| Q1 2026 | $12.3M | 212.3K | — | — |
| Q1 2026 | $1.3M | 21.9K | — | — |
| Q1 2026 | $731K | 12.6K | — | — |
| Q1 2026 | $64K | 1.1K | — | — |
| Q1 2026 | $66.6M | 1.14M | — | — |
| Q1 2026 | $206.9M | 3.56M | — | — |
| Q1 2026 | $14.6M | 251.7K | — | — |
| Q1 2026 | $14.1M | 241.6K | — | — |
| Q1 2026 | $1.1M | 19.1K | — | — |
| Q1 2026 | $11K | 197 | — | — |
| Q1 2026 | $4.8M | 82.2K | — | — |
| Q4 2025 | $2.5M | 55.2K | — | — |
| Q4 2025 | $447K | 10.0K | — | — |
| Q4 2025 | $10K | 230 | — | — |
| Q4 2025 | $899K | 20.1K | — | — |
| Q4 2025 | $7.8M | 173.3K | — | — |
| Q4 2025 | $1M | 22.5K | — | — |
| Q4 2025 | $440K | 9.8K | — | — |
| Q4 2025 | $14K | 315 | — | — |
| Q4 2025 | $44.7M | 998.0K | — | — |
| Q4 2025 | $147.1M | 3.28M | — | — |
| Q4 2025 | $10.1M | 225.2K | — | — |
| Q4 2025 | $10M | 223.6K | — | — |
| Q4 2025 | $826K | 18.4K | — | — |
| Q4 2025 | $18K | 396 | — | — |
| Q4 2025 | $2.7M | 61.1K | — | — |
Other funds holding XENE
$413.3M
$405.6M
$348.7M
$278M
$275.9M